The Global DNA Sequencing Market to Grow at 17.21% CAGR by 2028

Triton Market Research presents the Global DNA Sequencing Market report segmented by Product (Instruments & Consumables [Type {Consumables; Instruments}; Platform; {Sanger; NGS (Targeted Resequencing; RNA Sequencing; Whole-genome Sequencing; Whole-exome Sequencing; De Novo Sequencing; Chip Sequencing; Methyl Sequencing)}]; Sequencing Services; Bioinformatics); by Technology (Ion Semiconductor Sequencing; Sequencing by Synthesis; Pyrosequencing; Chain Termination Sequencing; Single-molecule Real-time Sequencing (SMRT); Nanopore Sequencing; Sequencing by Ligation (SBL); Other Technologies); by Application (Diagnostics; Biomarker Discovery; Reproductive Health; Biomarker Discovery; Drug Discovery; Personalized Medicine; Forensics; Agriculture & Animal Research; Other Applications); by Industry Verticals (Pharmaceutical; Research Centers and Academic & Government Institutes; Hospitals & Clinics; Biotechnology Companies; Other Industry Verticals); by Geographical Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), discussing Market Summary, Industry Outlook, Impact of COVID-19, Key Insights, Porter's Five Forces Analysis, Industry Components, Key Impact Analysis, Market Attractiveness Index, Vendor Scorecard, Key Market Strategies, Drivers, Restraints, Opportunities, Competitive Landscape, Research Methodology & Scope, Global Market Size, Forecasts & Analysis (2021-2028).

Triton Market Research forecasts the Global DNA Sequencing Market to evolve at a CAGR of 17.21% over the estimated phase 2021-2028.

The Asia-Pacific region accounts for 50% of the world's new cancer cases every year, and, by 2030, cancer deaths in the region are expected to rise by 36%. A genomic period of cancer-related studies is progressing rapidly, fueled by the introduction of next-generation sequencing techniques offering sharp resolution. Therefore, the rising prevalence of cancer cases is a major factor driving the studied market growth. However, limitations associated with informatics in DNA sequencing are a major hindrance to the growth process.

The Asia-Pacific DNA sequencing market is projected to grow at the fastest rate, globally, over the forecasting years. The market in this region possesses immense potential for the development of DNA sequencing. This can be attributed to the increase in demand for drug discovery and a rise in R&D activities. In addition, support from the government and the rising number of investments from the private sector, along with the increase in focus on the biotechnology sector, will further amplify the growth.

Pacific Biosciences of California Inc, Illumina Inc, Agilent Technologies Inc, Asuragen Inc, F Hoffmann-La Roche, Thermo Fisher Scientific Inc, Merck KgaA, Eurofins Scientific, Siemens Healthineers AG, BGI Genomics, Adaptive Biotechnologies Inc, Perkinelmer Inc, Spiral Genetics Inc, Bio-Rad Laboratories Inc, and Danaher Corporation (Integrated DNA Technologies Inc) are some of the dominant players in this market.

With the outbreak of the COVID-19 pandemic, the market observed a sudden spike in demand for DNA sequencing and related technologies. The industry is dominated by big players, such as Agilent Technologies, Thermo Fisher Scientific, Illumina Inc, etc. And they have started adopting innovative technologies and manufacturing technologically advanced products. While researchers continue their work on therapeutics and diagnostics, the adoption of new technologies, price competition, and innovation, are some key factors leading to the strong competitive rivalry.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.